MAKE YOUR FORTUNE
PARTNERING WITH US
TO LAUNCH A
Peptide Life Center
IN YOUR COMMUNITY.
Featuring our patented Triple-G Weight Loss Metabolic Reset Journey and advanced FDA-approved non-surgical skin tightening technologies.
Protected by U.S. Patent, our GLP-1 / GLP-2 / GLP-3 (Triple-G) weight loss medication is a major part of our 20-week Metabolic Reset Journey.
Weekly Injection with NO DOCTORS • NO PHARMACIES • NO PRESCRIPTIONS
"…the world's most powerful weight-loss drug…"
— The Atlantic
Est. 1857 · Pulitzer Prize-winning publication
Weekly Injection · No Doctors · No Pharmacies · No Prescriptions
THE SYSTEM IS BUILT TO KEEP
You Dependent
Prescription GLP-1 drugs cost $1,000–$1,500 per month. When patients stop, every pound returns. The pharmaceutical system profits from lifetime customers — not patients who get well.
Peptide Associates offers a fundamentally different model — a structured, time-limited 20-week Metabolic Reset Journey with a defined endpoint, no prescriptions, and a cost patients can actually afford.
The pharmaceutical system does not profit from patients who get well. It profits from lifetime customers on monthly prescriptions. Ozempic® and Wegovy® are priced accordingly — $1,200+ per month, ongoing doctor visits required, and when you stop, every pound returns by design.
Bariatric surgery costs $25,000–$35,000 with permanent risks. Fad diets fail 95% of the time by design. And unregulated online peptides lack quality control entirely. The market is broken — and that's exactly why this opportunity exists.
Insurance rarely covers it. Supply is inconsistent. Weight returns the moment you stop. Built-in dependency by design.
Permanent alteration of your digestive system. Long-term risks include malnutrition, ulcers, bowel obstruction, and more.
Studies confirm: 95% of diets fail. The industry profits from repeated failure — not your success.
Most sellers label products "not for human consumption." No quality control. No dosing accuracy. Real risk.
HOW THE PEPTIDE LIFE CENTER
Works
From the first free scan to a 20-week metabolic transformation — here is exactly how the patient journey flows through your clinic.
The Peptide Life Center model is built on one simple insight: give people undeniable proof that something is wrong, and they will take action to fix it.
That's what the free 60-second body composition scan does. It shows patients exactly where their fat is, how much lean muscle they're losing, their biological versus chronological age, and precisely how long it will take to fix. The data creates urgency. The program delivers results.
60-second scan. 25 metrics. Printed 2-page report. Perceived value: $299. Cost to clinic: nothing. Over 75% enroll same day.
Patient begins the 20-week Metabolic Reset Journey with a weekly self-injection at home. Starting dose wholesale: $72. Retail: $197–$497. 60%+ net margin.
Triple-G suppresses appetite, optimizes insulin efficiency, and elevates resting metabolic rate. 91% continue month after month.
Every weight-loss patient becomes a skin tightening prospect. Partners charge $149/session or $997 for 8 sessions — far below competitors' $500–$1,000.
WHY TRIPLE-G IS IN
A CLASS OF Its Own
Retatrutide targets three distinct metabolic pathways simultaneously. No other therapy comes close. Physicians responded with spontaneous applause when Phase 3 data was presented.
"…the world's most powerful weight-loss drug…" — The Atlantic, Pulitzer Prize-winning publication.
Retatrutide / GLP-3 works by targeting three distinct metabolic pathways simultaneously. No other single therapy — prescription or otherwise — achieves this triple-action mechanism. When Phase 3 clinical data was presented at a major medical conference in 2023, physicians responded with spontaneous applause.
Mimics the GLP-1 hormone to reduce hunger, slow gastric emptying, and promote early satiety. The brain stops signaling hunger before the body needs fuel.
Enhances nutrient processing, improves insulin response, and reduces GI side effects commonly associated with pharmaceutical GLP drugs.
Increases resting metabolic rate — enabling the body to burn significantly more calories even at rest. The calorie-burning engine runs 24/7.
| Therapy | Mechanism | Avg. Weight Loss | Prescription? | Monthly Cost |
|---|---|---|---|---|
| Triple-G / GLP-3 (Peptide Associates) | GLP-1 + GIP + Glucagon | ~29% | No | ~$200–$497 |
| Ozempic® (Semaglutide) | GLP-1 only | ~15% | Yes | $1,000–$1,500+ |
| Mounjaro® (Tirzepatide) | GLP-1 + GIP | ~20% | Yes | $1,000–$1,200+ |
| Bariatric Surgery | Anatomical restriction | ~25–30% | Yes | $25,000–$35,000 one-time |
| Commercial Diet Programs | Calorie restriction | ~5–10% | No | $300–$1,000+ |
"…the world's most powerful weight-loss drug…"— The Atlantic (Pulitzer Prize-winning publication)
The Atlantic — Pulitzer Prize-Winning Publication
The Atlantic's landmark coverage brought international attention to retatrutide's Phase 3 clinical trial results — results so dramatic that physicians responded with spontaneous applause when the data was first presented at a major medical conference in 2023.
The World's Most Powerful Weight-Loss Drug
You're not supposed to be able to buy Retatrutide — but some people have found a way. And its results are jaw-dropping.
"Patients lost on average 71 pounds — double what people lose on Ozempic. Some stopped because the drug was too effective."
— The Atlantic, January 2026 Phase 3 Clinical Trial Report"You're not supposed to be able to buy the world's most powerful weight-loss drug, but some people have found a way." So begins The Atlantic's exhaustive investigation into Retatrutide — nicknamed GLP-3 — a drug that is rewriting everything we thought we knew about obesity medicine.
As the nickname GLP-3 implies, retatrutide is like a GLP-1 drug — but more, more, more. It is more effective, has more modes of action, and induces more weight loss. It may in fact be the most powerful weight-loss drug ever created.
When early retatrutide data were presented at a medical conference in 2023, a scientist who was there told The Atlantic the usually staid audience burst into spontaneous applause.
Phase 3 Results: Double the Weight Loss
Two weeks ago, the first of the highly anticipated Phase 3 clinical-trial results corroborated the jaw-dropping initial numbers: patients lost on average 71 pounds, or 29 percent of their body weight — double what people lose on semaglutide, better known as Ozempic or Wegovy.
Some trial participants stopped retatrutide early because they had lost too much weight — because the drug was simply too effective.
A Biologist's 100-Pound Journey
As a biologist herself, Elizabeth was comfortable working with needles and reading scientific papers. She modeled her dosing regimen on the clinical-trial protocol. She has lost more than 100 pounds in the past two and a half years — first on older drugs and the last 50 or so on retatrutide.
"After a lifelong struggle with obesity, these are some of the most amazing events of my whole life."
Anticipation Reaches Fever Pitch
The frenzy over retatrutide has kicked into even higher gear since the Phase 3 results were announced this month. GLP-1 prescriptions shot up from about 1 million at the start of 2018 to about 9 million in 2022. Retatrutide, researchers believe, could dwarf those numbers.
The Atlantic has been published since 1857 and the Pulitzer Prize-winning monthly continues to investigate the stories that define our era.
7 SECRETS DOCTORS & BIG PHARMA
DON'T WANT YOU TO KNOW
About Triple-G / GLP-3
The prescription weight loss system is not designed to make you well. It is designed to keep you dependent. Here is what they are hoping you never find out.
The weight loss industry generates over $300 billion annually in the United States. Yet study after study confirms that 95% of diets fail. Those two facts don't coexist by accident.
The Prescription System Is Designed to Keep You Paying — Not to Make You Well
Ozempic®, Wegovy®, and Mounjaro® cost $1,000–$1,500 per month, require ongoing doctor visits, and are frequently unavailable due to supply shortages. When patients stop taking them, every pound returns.
The Most Powerful Weight Loss Compound Ever Discovered Doesn't Require a Prescription
FDA guidelines classify peptides exceeding 40 amino acids as prescription drugs. Our proprietary GLP-3/Triple-G formula has been independently verified at 39 amino acids — keeping it within supplement classification, legal to distribute in all 50 states.
What's Being Sold on TikTok and YouTube Is Dangerous — and Mostly Illegal
Most online peptide sellers label products "not for human consumption." Peptide Associates operates at the opposite end of this spectrum: GMP-certified, ISO 5, third-party verified, with Board-Certified legal counsel and full product liability insurance.
Exercise Alone Will Not Save You — and Your Doctor Knows It
Research is unambiguous: exercise alone cannot drive significant weight loss. Triple-G addresses weight loss at the metabolic level. No grueling workout required.
Weight Loss Surgery Carries Risks Your Surgeon Probably Downplayed
Bariatric procedures run $25,000–$35,000. Long-term side effects include malnutrition, bowel obstruction, ulcers, hernias, and chronic vomiting. Compare that to a nonprescription weekly injection at home for a few hundred dollars a month.
The Free Scan That Shows Patients Exactly What's Happening Inside Their Body
A 60-second body composition scan checks 25 body metrics and produces a printed 2-page report on the spot. It costs the clinic nothing and carries a perceived value of $299. Over 75% of patients enroll the same day.
Most Popular Weight Loss Programs Are Designed for You to Fail
The Peptide Associates 20-week Metabolic Reset Journey breaks this cycle by resetting the underlying metabolic pathways that govern hunger and fat storage — not temporarily suppressing them.
Oprah Winfrey — Public Statement, 2024
"I've been on the medication for the past year and a half..."
After decades of public struggle with weight, Oprah Winfrey publicly credited GLP-class medications as the tool that finally worked — helping legitimize the entire category in the eyes of tens of millions of consumers.
Dr. Ania Jastreboff & Oprah Winfrey
Co-authors of Enough — 2026 Bestseller
Backed by Science · Discussed by Oprah · Changing Everything
"THE FUTURE OF
WEIGHT LOSS
HAS ARRIVED"
"Obesity is NOT a failure of willpower."
A groundbreaking 2026 bestseller reveals what millions are just beginning to understand:
THE FULL PARTNER
OPPORTUNITY Letter
The complete breakdown of the business model, two income streams, operations, marketing system, and investment structure. Read this before your call.
Fellow Entrepreneurs & Investors:
Make your fortune partnering with us to launch a Peptide Life Center in your community.
Drive through your city and you'll see weight-loss clinics everywhere. Demand is exploding — and that's exactly why this opportunity is so powerful. We offer a different path, featuring our patented GLP-3/Triple-G Weight Loss Metabolic Reset Journey and advanced FDA-approved non-surgical skin tightening technologies.
Protected by 5 U.S. Patents, our nonprescription GLP-1 / GLP-2 / GLP-3 ("Triple-G") medications are the core of our proven 20-week Metabolic Reset Journey.
"…the world's most powerful weight-loss drug…"
— The Atlantic (Pulitzer Prize-winning publication)1. Triple-G Metabolic Reset 20-Week Journey (Weight Loss) — Starting dose wholesale cost: $72. Average retail: $197–$497. Minimum $250/month average profit per patient.
2. Non-Surgical Skin Tightening Treatments — FDA-approved, non-invasive technology addressing loose skin caused by rapid weight loss.
We are only working with a limited number of entrepreneurs in each state.
The weight loss and wellness industry is exploding, fueled by prescription GLP-1 breakthroughs like Ozempic®, Wegovy®, and Mounjaro®. Patients are sick of empty promises. They're desperate for a real answer.
Our medications were created by a team of doctors and scientists at our U.S.-based GMP-certified, FDA-regulated lab. We offer over 75 nonprescription peptides in the weight-loss and longevity markets.
| Competitors | Peptide Associates Partners |
|---|---|
| Equipment cost: $200,000+ | No activation charge required |
| $135 per-session activation fee (passed to patient) | Just $149/session or $897 for 6 |
| $6,000 for 6 treatments to patient | Monthly membership for ongoing residual income |
New clinics can be operational within 30 days in a small, centrally located office — ideally 500–700 square feet. We help partners secure executive suite space within 1–2 days, already staffed with a receptionist, phones, internet, and furniture.
We recommend two staff members. No high-pressure sales experience required — just good communication skills and the ability to follow our proven system.
We offer a FREE $299 Body Composition Diagnostic Report. Better than 75% of prospects sign up on the same day.
Our direct-response ad agencies have invested over $20 million testing cost-effective lead generation across digital PPC, SEO, Facebook, Instagram, TikTok, radio, TV, and direct mail.
Many patients remain on treatment indefinitely to maintain their results, creating a powerful base of recurring revenue.
This is not a franchise. Partners own 100% of their local clinic.
Partners pay a one-time $99,700 Re-earnable Performance Deposit, fully rebated back via deep discounts on already-competitive wholesale pricing.
In return, we provide our complete protocol, exclusive wholesale access to all of our peptides, and our extensive intellectual property — much of it developed by Dan Kennedy's team. You'll receive a true turnkey system.
Partners should budget approximately $20,000 in additional initial operating capital. Specialized niche health businesses like ours typically sell at five times gross sales.
Contact our staff for a brief conversation to learn which states and areas are still available. We are selective — we work only with people we believe have what it takes to succeed.
Thank you for your interest. We look forward to speaking with you soon.
Cordially,
Austin Hornsby, MBA
V.P. International Sales and Marketing
Nonprescription Clinical, LLC
(702) 714-3100
P.S.
As part of the rebateable $100,000 Performance Deposit, we are now including a FREE Skin Tightening Body Contouring Machine and a FREE Body Analysis Scan Machine for all new partners. Comparable equipment sells for upwards of $100,000+.
Call to discuss an additional MAJOR ad agency incentive — a $14,000 value — that includes: a custom video of your clinic, a personalized $5,000 world-class website, two months of digital advertising budget, and four months of paid SEO.
EVERY QUESTION PARTNERS ASK —
Answered
From legal classification and compliance to staffing, marketing, and wholesale pricing. Click any question to expand the answer.
Call now: (702) 714-3100
INCREDIBLE IN-STORE
Lead Generation
Co-branded wellness kiosks placed inside major grocery, drug store, and blood lab chains — generating a continuous stream of qualified, motivated leads directly to your clinic.
Weight Loss and Peptide Clinic Lead Generation
INCREDIBLE LEAD
GENERATION SOURCE
CO-BRAND WITH
MAJOR RETAILERS
+ Quest Diagnostics blood lab locations nationwide
BUILT THE Right Way
FROM THE START
Our laboratory, legal, and operational infrastructure is not an afterthought — it is the foundation that protects every partner, every patient, and the entire enterprise.
When you partner with Peptide Associates, you are backed by a compliance infrastructure that has been years in the making — and that no unqualified competitor can replicate.
FDA guidelines classify peptides over 40aa as prescription drugs. Our formula is independently verified at 39aa — maintaining supplement classification and legal distribution to all 50 states.
Our U.S.-based laboratory operates under GMP certification, ISO 5 cleanroom standards, strict regulatory guidance, and carries significant product liability insurance.
Legal oversight by Florida Healthcare Law, led by Jeffrey Cohen, Esq., a Board-Certified Specialist in Health Law. Full legal opinions and patent documentation available during due diligence.
Our nonprescription GLP-1 / GLP-2 / GLP-3 medications are protected by five U.S. Patents. You partner with a proprietary system — not a commodity anyone can replicate.
Products sold exclusively through licensed partner clinics. Never direct-to-consumer. Never on Amazon. This structure maintains marketplace integrity and protects every partner's territory.
Our core team has worked together for over 17 years and has launched hundreds of clinics. This is an established, proven enterprise — not a startup with unverified claims.
All peptide products must be sourced exclusively through Nonprescription Clinical, LLC / Peptide Associates. GMP-certified, ISO 5, third-party verified batches only.
All products distributed must maintain their supplement classification. Partners may not make prescription-drug claims. All marketing must align with approved intellectual property.
All patients must complete a body composition scan prior to enrollment. Informed consent forms required. Partners must follow the 20-week protocol scripts as trained during onboarding.
At minimum one staff member must complete the Certified Wellness Coach course prior to seeing patients. All staff must complete the Peptide Associates onboarding training program before launch.
Partners must use approved marketing templates and scripts. No unauthorized health claims, before/after photos without consent, or unverified testimonials permitted.
Partners may not sell outside their designated territory or through any e-commerce channel. Products must be sold exclusively through the licensed partner clinic to end patients only.
"Our compliance infrastructure isn't a legal disclaimer. It's a competitive moat. No unqualified operator can build what we've built in a day, a month, or a year."
— Peptide Associates Compliance OverviewYOUR MARKET
IS OPEN
RIGHT NOW
We select only a small number of partners per state. Once a territory is committed, it is gone. The entrepreneurs who act first own the patients, the relationships, and the profits.
THE GOLD RUSH
Is Here
Medical Marketing & Media's landmark investigation: $100B+ projected annually, Influencers like Joe Rogan and RFK Jr. driving mass awareness, and the professional-channel market just beginning to open.
Medical Marketing and Media
GET READY FOR THE
PEPTIDES GOLD RUSH
A heavy combination of influencers, deregulation, GLP-1 success stories and Do-It-Yourself medicine are driving the phenomenal growth in peptides. But are they safe?
Peptides are becoming a foundational part of the DIY health movement, spurred on by the success of GLP-1s.
"Influencers like Joe Rogan are driving interest in the use of peptides."
THE ROGAN EFFECT
Influencers don't get much more influential than Joe Rogan. With nearly 20 million Instagram followers and over 35 million subscribers across Spotify and YouTube, Rogan reaches one of the largest male audiences in media — roughly 80% of his listeners are men.
This reach helps explain why U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. chose Rogan's podcast in late February to preview a shift in federal policy.
THE WOLVERINE STACK
Rogan has emerged as one of the most visible public advocates of these compounds, discussing BPC-157 — part of the so-called "wolverine stack."
"The pain was gone in two weeks."
— Joe Rogan on BPC-157Rogan said he began experimenting with BPC-157 to treat elbow tendinitis. After beginning injections, the pain was gone in two weeks.
Analysts widely project that the global GLP-1 category could exceed $100 billion annually before the end of the decade.
THE PARALLEL MARKET
As pharmaceutical companies were building this blockbuster class of medicines, a parallel peptide marketplace was developing outside the traditional regulatory framework.
WHAT ARE PEPTIDES?
Peptides are short chains of amino acids that function throughout the body as signaling molecules. Many naturally occurring hormones, including insulin and GLP-1, are peptides.
COMPOUNDS IN CIRCULATION
Online forums and fitness influencers routinely discuss these compounds for athletic recovery, sexual performance, and improved sleep quality.
THE PARALLEL ECOSYSTEM
A parallel ecosystem of longevity clinics and telehealth providers has emerged offering supervised peptide therapy programs, often costing patients several thousand dollars per year.
BUT ARE THEY SAFE?
The convergence of influencer demand, a booming GLP-1 market, and shifting federal policy is creating one of the most significant inflection points in modern health and wellness.
THE GOLD RUSH IS HERE. ARE YOU POSITIONED FOR IT?
"The unregulated Wild West is closing. The regulated, professional-channel peptide market is just opening — creating one of the biggest health and wellness opportunities of the decade."
— Steve Madden, Medical Marketing & Media, March 2026